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I KACh is present in the sinoatrial node, atria, atrioventricular node, and possibly Purkinje fibers of the mammalian heart (27) . The cloning of GIRK1 and GIRK4, which constitute cardiac inward rectifier potassium channels by forming heterotetramers, has allowed a more detailed understanding of how heterotrimeric G proteins activate K ACh (16) . G␤␥-subunits that are released from pertussis toxin-sensitive G proteins after stimulation of M 2 muscarinic receptors (or adenosine-1 receptors) directly activate K ACh via a membrane-delimited mechanism (1, 15, 18) .
The aim of the present study was to investigate the physiological role of G protein ␤␥-subunits for heart rate control and arrhythmia vulnerability in vivo using electrocardiographic telemetry and intracardiac electrophysiological stimulation. To that end, we generated a transgenic mouse model with a reduced amount of G␤␥-subunits in cardiocyte membranes due to cardiac-specific overexpression of nonprenylated G␥ 2 -subunits.
G protein ␤␥-subunits are attached to the plasma membrane by a prenyl group on the carboxyl terminus of all G␥-subunits (5) . In a multistep series of posttranslational modifications, the G␥-subunits are either farnesylated or geranylgeranylated at position Ϫ4 from the carboxyl terminus, followed by proteolytic removal of the last three amino acids and methyl esterification of the resultant terminal carboxyl group. Isoprenylation can be blocked by mutating the cysteine in the COOH-terminal CXXR motif to serine. Absence of the lipid modification does not prevent the formation of G␤␥ complexes, but without this lipid modification, G␤␥ is no longer membrane bound and unable to activate effectors (10) .
We reasoned that overexpression of nonisoprenylated G␥-subunits in hearts of transgenic mice would diminish the amount of active, membrane-bound G␤␥ because nonisoprenylated G␥ should compete with endogenous G␥ for assembly with G␤. We chose G␥ 2 [C68S] for these studies because it assembles well (35) with the G␤-subunits expressed in the heart: G␤ 1 , G␤ 2 , and G␤ 4 (9, 30, 32) . G␥ 2 , itself, is not found in the heart (9) , but this is of no consequence, because the only function of its mutated, nonprenylated form is to trap as many G␤-isoforms as possible.
We hypothesized that a reduction in the amount of endogenous G␤␥-subunits in cardiac membranes would blunt the response of the intact animal to the negative chronotropic effects of the muscarinic receptor agonist carbachol and could potentially be protective against vagally mediated atrial arrhythmias.
MATERIALS AND METHODS
Generation of transgenic mice. The cDNA for bovine G␥2 was modified to carry an NH2-terminal hemagglutinin (HA)-epitope and a C68S mutation by PCR using the primer pair 5Ј-GTCGACGCCGCCATGGTATCCTATCCATAC-3Ј and 5Ј-AAGCTTTTAAAGGATAGCAGAGAAAAAC-3Ј and a previously described HA␥2 cDNA as template (21) . The PCR product HA␥2[C68S] was ligated into the T-Vector (Promega), and the DNA sequence was verified. The 0.28-kb SalI-HindIII HA␥ 2[C68S] cDNA fragment was ligated into the corresponding sites of a pGEM-9Zf vector (kindly provided by Dr. W. J. Koch) containing the murine ␣-myosin heavy chain promoter (5.5 kb) and a simian virus 40 intron/polyadenylation signal. A 6.63-kb linear cDNA fragment was released with SacI and NotI. Transgenic FVB mice were generated by the transgenic mouse facility of Harvard Medical School and were identified by Southern blot and PCR with the use of a cDNA probe or primers specific for the transgene.
All protocols fully conformed to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH Publication 85-23, Revised 1996), American Association of the Accreditation of Laboratory Animal Care, Harvard Medical School, Brigham and Women's Hospital, and Children's Hospital Animal Care and Use Committees.
Cardiocyte isolation. Hearts from wild-type and transgenic mice of different ages were excised and Langendorff perfused with Ca 2ϩ -free Tyrode's solution containing (in mM) 140 NaCl, 5.4 KCl, 1 MgCl2, 1 Na2HPO4, 5 HEPES, and 10 glucose (pH 7.3). After 3-5 min of perfusion with noncirculating Tyrode's solution, the heart was perfused for 15 min with recirculating Ca 2ϩ -free Tyrode's solution containing collagenase II (0.6 mg/ml, Worthington), protease XXIV (0.1 mg/ml, Sigma), bovine serum albumin (1 mg/ml), and fetal calf serum (2%). The flaccid heart was removed from the cannula, the atria were trimmed away, and the ventricular tissue was minced in Tyrode's solution containing 0.2 mM Ca 2ϩ . The majority of cells were released by gentle pipetting. The supernatant containing the isolated cells was centrifuged at 50 g for 3 min, washed twice with Tyrode's solution (0.2 mM Ca 2ϩ ) and once with phosphate-buffered saline, and then counted. The cells were kept in a low-Ca 2ϩ solution because the two major cardiac adenylyl cyclase (AC) isoforms (AC V and AC VI) are sensitive to direct inhibition through Ca 2ϩ (28) . The final cell pellet was snap-frozen and stored at Ϫ80°C until further use.
Membrane and cytosol preparation. Atrial and ventricular cardiac tissue were homogenized as previously described (20) . Isolated cardiocytes from one heart (1-2 ϫ 10 6 cells) were thawed and homogenized in 500 l of ice-cold Tris buffer [50 mM Tris ⅐ HCl, pH 7.6, 1 mM EDTA, and 1 mM dithiothreitol plus proteinase inhibitors (3 mM benzamidine and 1 g/ml of each soya and lima bean trypsin inhibitor and leupeptin)] with a hand-held tissue tearer (5 bursts of 10 s at 8-10,000 rpm). To separate the cytosolic and membrane fractions, both tissue and myocyte samples were centrifuged at 100,000 g for 30 min at 4°C. Protein was measured using the Bradford Microassay (Bio-Rad) with bovine serum albumin as standard (4) .
Western blot analysis. Equal amounts of membrane and cytosolic protein were separated on 10% (G␣-subunits), 12% (G␥-subunits), or discontinuous 12%/17% gradient (G␤-and G␥-subunits) SDS-PAGE and transferred to nitrocellulose membranes. Immunoblots were performed as previously described (20) using antibodies against G␣ s (sc-383, 1:1,000, Santa Cruz Biotechnologies), G␣i (AS/7, 1:1,000, NEN Life Science Products), G␣q/11 (C-19, 1:1,000, Santa Cruz Biotechnologies), G␤ (␤common, 1:1,000, Upstate Biotechnologies), G␥2 (␥2EDPL, 1:500, gift from Dr. W. Simmonds), and the HA epitope (12CA5, 1:1,000, BAbCO). Band intensity was determined by scanning and computerized densitometry using the NIH Image 1.61 software.
Coimmunoprecipitation experiments. Ventricular cytosolic protein (500 g) was incubated with a HA antibody (12CA5, 2 l, BAbCo) in RIPA buffer containing 50 mM Tris⅐HCl, pH 8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS plus proteinase inhibitors (3 mM benzamidine and 1 g/ml of each soya and lima bean trypsin inhibitor and leupeptin) at 4°C overnight. Protein A Sepharose (35 l of a 50% slurry of CNBr-activated Sepharose Cl-4B, Sigma) was added and tumbled for another 2 h. Samples were pelleted and washed three times with 1 ml of RIPA buffer followed by one wash in detergent-free buffer. The final pellets were resuspended in Laemmli sample buffer and heated to 95°C for 5 min. The supernatants, along with 100 g of cytosolic starting material, were loaded onto a discontinous 12-17% gradient SDS-PAGE gel and transferred to nitrocellulose membrane. The upper and lower parts of each membrane were probed by Western blotting (see Western blot analysis) with antibodies against G␤ and G␥2, respectively.
Adenylyl cyclase assay. Ventricular cardiomyocyte membranes (15-20 g protein/assay) from 9-wk-old HA␥2-79h and wild-type mice were incubated for 20 min at 37°C, and the AC activity was determined as described previously (22) . In brief, the 50-l reaction cocktail contained 1 mM ATP (1 Ci [␣-
32 P]ATP/tube), 5 mM Mg acetate, 0.1 mM cAMP, 1 mM dithiothreitol, 0.1 mg/ml bovine serum albumin, 1 mM isobutylmethylxanthine, 25 mM Tris acetate, pH 7.6, 5 mM creatine phosphate, 50 U/ml creatine kinase, and 10,000 cpm [ 3 H]cAMP. For stimulation of AC activity, 100 M GTP␥S, 10 M isoproterenol, 100 M forskolin, or a combination thereof, were added. cAMP was purified by precipitation of other nucleotides with ZnCO3 and on alumina columns and quantitated by scintillation counting. The recovery was 70-80%.
Animals used for telemetry and electrophysiological studies. All experiments were performed on HA␥2-79h mice (n ϭ 21) and sex-and age-matched wild-type mice (n ϭ 38) from the same inbred strain (FVB). The mean age was 14 wk (range 12-16 wk), and the average weight was 30.8 Ϯ 1.8 g. The body weight was similar in HA␥2-79h (30.2 Ϯ 0.6 g) and wild-type mice (31.4 Ϯ 2.5 g). Mice were housed two to four per cage at 24°C in a facility with 12:12-h light-dark cycles and allowed free access to water and food.
Heart rate and heart rate variability. The techniques used for recording ambulatory long-term electrocardiograms (ECGs) by telemetry and for the analysis of heart rate and heart rate variability (HRV) are described in detail elsewhere (8) . Carbamylcholine chloride (carbachol, 0.5 mg/kg ip) was administered to evaluate the effect of muscarinic receptor stimulation on heart rate regulation. Atropine (0.5 mg/kg ip) and propranolol (1 mg/kg ip) were injected 5 min before carbachol to block the parasympathetic and sympathetic autonomic responses, respectively. Both antagonists were administered for combined autonomic blockade to assess "intrinsic heart rate." Baroreflexmediated cardioinhibitory responses were tested in wild-type and transgenic mice that underwent pressure challenge with phenylephrine hydrochloride (3 mg/kg ip) after ␤-adrenergic blockade with propranolol (1 mg/kg ip). ECG recordings and HRV analysis were performed 5-10 min after the drug administration to allow the heart rate to stabilize and preclude any direct effects of the intraperitoneal injection on ECG and HRV parameters (8) .
Electrophysiology studies. Surface six-lead ECGs were obtained from anesthetized mice (ketamine hydrochloride and pentobarbital; 0.033 mg/g each) by placing subcutaneous 27-gauge electrodes in each limb. For the endocardial approach, an octapolar mouse 1.7-Fr electrophysiology catheter (CIBer mouse electrophysiology catheter, NuMED; Hopkinton, NY) with precise interelectrode distances was advanced from the right internal jugular vein, exposed by cutdown, through the right atrium to the right ventricle. The proximal electrodes paced and recorded from the atrium while the distal electrodes allowed stimulation and signal acquisition from the right ventricle.
The in vivo mouse electrophysiology study protocol has been previously described in detail (3). Surface and intracardiac ECG recordings, pacing, and programmed electrical stimulation were performed at baseline and in response to carbachol (0.05 mg/kg ip). Standard pacing and programmed electrical stimulation protocols were used to determine atrial, atrioventricular nodal, and ventricular electrophysiological parameters. Sinus node function was evaluated as in clinical practice by measuring sinus node recovery time (SNRT) at pacing drive rates of 200, 150, and 100 ms with a duration of 15 s and the ratio SNRT to SCL ϫ 100%. For potential induction of atrial arrhythmias, right atrial burst pacing at rates of 40-80 ms and programmed right atrial stimulation a 150-ms cycle length, as well as the double and triple extrastimulus techniques, was performed as described (31) . Similar protocols were used to attempt provocation of ventricular arrhythmias.
Surface and intracardiac ECG recordings were acquired on a multichannel amplifier and converted to a digital signal for analysis. Pacing thresholds were determined, and stimulation was performed for 1.0-ms pulse widths at twice the diastolic threshold.
Statistical analysis. Data are reported as means Ϯ SD or SE for mice (n) as indicated. Statistical analysis was performed using paired and unpaired two-tailed Student's t-test, ANOVA with Scheffé's subgroup testing where appropriate, and analysis of interobserver variability. A P value of Ͻ0.05 was considered statistically significant.
RESULTS
Generation of transgenic mice. Two independent heterozygous mouse lines (HA␥ 2 -79 and HA␥ 2 -83) with cardiac-specific expression of nonisoprenylated, HAtagged ␥ 2 (HA␥ 2 [C68S]) were established. HA␥ 2 -79 mice were also bred to homozygousity (HA␥ 2 -79h). All mice were viable, had a normal lifespan, and showed no gross apparent phenotype compared with agematched wild-type mice.
Expression of protein encoded by the transgene. G␥ 2 is normally not expressed in the heart (9). Accordingly, we did not detect any endogenous G␥ 2 -subunits in the membrane (see Membrane/cytosol distribution and expression of G protein ␤-subunits) or cytosol (Fig. 1A ) of atrial and ventricular tissue from wild-type mice. The protein recognized by the G␥ 2 -specific antibody in the cytosol from wild-type (and transgenic) atria reflects cross-reactivity with a protein of unidentified origin. The protein encoded by the transgene, HA␥ 2 [C68S], was detected in the cytosol of both atria and ventricles from transgenic mice only (Fig. 1A ). In the absence of endogenous G␥ 2 , the protein recognized by either the G␥ 2 -or the HA-specific antibody (Fig. 1A , top and bottom, respectively) represents HA␥ 2 [C68S]. We used the G␥ 2 -specific antibody in subsequent Western blots because it yielded a stronger signal than the antibody against the HA epitope. As expected for unprenylated G␥, no HA␥ 2 [C68S] was found in the membrane (see below, Fig. 2A ).
The expression level of HA␥ 2 [C68S] protein differed between the transgenic lines. Homozygous HA␥ 2 -79h mice expressed 30-40% more HA␥ 2 [C68S] than their heterozygous counterparts (Fig. 1B) . HA␥ 2 -83 mice expressed less HA␥ 2 [C68S] than mice from line HA␥ 2 -79 (data not shown). In all three lines, HA␥ 2 [C68S] expression increased over time. In HA␥ 2 -79 ventricles, for example, the amount of cytosolic HA␥ 2 [C68S] increased approximately twofold between 3 wk and 6 mo of age (Fig. 1B) . A similar increase was observed in the atria, as shown for HA␥ 2 -79 mice in Fig. 1A .
Membrane-cytosol distribution and expression of G protein ␤-subunits. The effect of unprenylated HA␥ 2 [C68S] on the membrane-cytosol distribution of G␤ protein was tested in Western blots using a ␤ common -antibody, which recognizes G␤ 1 , G␤ 2 , and G␤ 4 (as confirmed with Sf9 cell extracts expressing different G␤ isoforms; data not shown). No change in G␤ distribution was detectable in atrial and ventricular tissue (data not shown), presumably due to the considerable number of nonmyocytes in cardiac tissue, which do not express HA␥ 2 [C68S] but contribute to the overall G␤ pool. In contrast, the amount of membrane-bound G␤ was greatly reduced in isolated cardiocytes from ventricles of mice from all lines, whereas, conversely, the amount of cytosolic G␤ was increased ( Fig. 2A) . The limited number of atrial myocytes precluded us from carrying out a similar analysis in atria. Figure 2A also 1C) and solubilized membrane samples from transgenic (or wild type) mice (data not shown).
To determine whether the rise in HA␥ 2 [C68S] expression as the mice grew older was accompanied by a more pronounced decrease of membrane-bound G␤ protein, we measured the amount of G␤ in cardiocyte membranes from HA␥ 2 -79 mice over time and compared it with agematched littermate controls (Fig. 2B) . In wild types, the amount of G␤ increased threefold by 22 wk compared with the level expressed at 4 wk. This developmental increase was markedly blunted in HA␥ 2 -79 mice, which showed almost no change in the level of membranebound G␤ between 4 and 22 wk of age. As a result, the amount of membrane-bound G␤ in 22-wk-old HA␥ 2 -79 mice amounted to only 26 Ϯ 6% of the level of G␤ in age-matched wild-type mice. Thus the decline in the relative amount of membrane-bound G␤ compared with wild-type mice was more pronounced in older transgenic mice, presumably due to the increase in expression of
Expression of G protein ␣-subunits. We examined whether the amount of G protein ␣-subunits is altered in cardiocyte membranes from HA␥ 2 -79 mice (Fig. 2B) . Similar results were obtained in HA␥ 2 -79h mice (see below) and HA␥ 2 -83 mice (data not shown). In wild-type mice, the amount of G␣ i (assessed with the AS/7 antibody, which recognizes all three G␣ i subtypes) increased twofold by 22 wk of age, whereas G␣ s and G␣ q/11 remained largely unchanged over time. In transgenic mice, the amount of both G␣ s isoforms was decreased compared with the wild-type mice over the entire period. G␣ i protein levels were slightly, but significantly, decreased in 22-wk-old transgenic mice. There was no change in the amount of G␣ q/11 at any time.
We asked whether the reduction in G␣ s had functional consequences on its immediate downstream tar- get AC. Compared with wild-type mice (n ϭ 3-6), the AC activity (in pmol cAMP ⅐ min Ϫ1 ⅐ mg protein
Ϫ1
) was diminished by 50-60% in myocyte membranes from 9-wk-old transgenic mice (n ϭ 3-5) in response to different stimuli: 100 M GTP␥S ( Heart rate and ECG intervals in conscious, unrestrained mice. The following experiments were performed on 12-to 16-wk-old HA␥ 2 -79h mice, which showed the most pronounced reduction of membranebound G␤ among the different lines and featured comparable changes in the G protein ␣-subunit expression (Fig. 2C) . Age-and sex-matched wild-type mice were used as controls. ECG parameters obtained from telemetric recordings showed no difference between HA␥ 2 -79h and age-matched wild-type mice at baseline (Table  1) . Within 2 min after carbachol injection, wild-type mice developed profound sinus bradycardia. The prolongation of the average sinus cycle length (and corresponding reduction in heart rate) was significantly blunted in the HA␥ 2 -79h mice (SCL increase by 99% in HA␥ 2 -79h vs. 274% in wild types, P Ͻ 0.05). There were no differences in the effects of carbachol on P-R interval, QRS duration, or corrected Q-T interval between groups. Figure 3A illustrates that the resting beat-to-beat mean heart rate obtained from continuous telemetric ECG recordings was ϳ700 beats/min in both wild-type and HA␥ 2 -79h unanesthetized, unrestrained mice. Notably, the heart rate showed less undulations in HA␥ 2 -79h (see below for HRV). Whereas carbachol caused a substantial and sustained decrease in heart rate in wild-type mice, this response was considerably blunted in HA␥ 2 -79h mice (Fig. 3B) . Results consistent with this observation were obtained in HA␥ 2 -83 mice (data not shown).
Heart rate variability. The results of time-domain and frequency-domain measures of HRV are summarized in Table 2 . Under baseline conditions, both timedomain and frequency-domain HRV parameters tended to be decreased in HA␥ 2 -79h mice compared with wildtype controls. Whereas some changes did not reach statistical significance, two time-domain indexes (standard deviation of the average R-R interval and coefficient of variance) and three frequency-domain indexes (low-frequency power, normalized frequency power, low frequency-to-high frequency power ratio) were significantly reduced. After muscarinic stimulation, wildtype mice exhibited a dramatic increase in all timeand frequency-domain parameters. In contrast, the effects of carbachol were profoundly blunted in HA␥ 2 -79h. Thus beat-to-beat fluctuations in the heart rate were reduced in transgenic mice compared with controls, particularly after carbachol challenge.
In a subgroup of 16 mice (10 wild type, 6 transgenic), arterial baroreflex sensitivity was assessed by elevating the arterial pressure with phenylephrine, resulting in increased vagal activity ( Table 2 ). As expected, the mean heart rate decreased in both groups of mice and the indexes of HRV increased. However, the effect was much less pronounced in HA␥ 2 -79h than in wild-type mice, suggesting a blunted vagal response. Taken together, the differences in time-and frequency-domain indexes of HRV and baroreflex sensitivity between HA␥ 2 -79h and controls indicate a major impairment of the parasympathetic heart rate control in the transgenic mice.
Effects of propranolol, atropine, and isoproterenol on heart rate. In a subgroup of mice (n ϭ 5 each), we performed parasympathetic and sympathetic autonomic blockade (using atropine and propranolol, respectively) and autonomic stimulation (using isopro- Electrocardiogram (ECG) measurements were obtained from telemetric recordings in the conscious state and represent means Ϯ SE for 14 mice. SCL, sinus cycle length; HR, heart rate; Q-Tc, QT/ (RR) 1/2 . Rate correction of Q-T intervals according to the formula of Mitchell et al. (23) . * P Ͻ 0.05 vs. wild-type controls; † P Ͻ 0.05 vs. baseline. Fig. 3 . Heart rate under basal conditions (A) and in response to muscarinic stimulation (B) in conscious, unrestrained WT and HA␥2-79h mice (T). Beat-to-beat heart rate was obtained from telemetered electrocardiogram (ECG) recordings. B: carbachol (0.5 mg/kg) was injected intraperitoneally at time 0. Data are means Ϯ SE for each time point from WT mice (n ϭ 19) and HA␥2-79h mice (n ϭ 16). terenol) and compared the heart rate response with the baseline state. Propranolol caused a comparable decrease in heart rate in HA␥ 2 -79h mice (Ϫ157 Ϯ 24 beats/min) and wild-type controls (Ϫ179 Ϯ 21 beats/ min). After atropine administration, the heart rate was indistinguishable between both groups (HA␥ 2 -79h: Ϫ14 Ϯ 3 beats/min; wild types: Ϫ13 Ϯ 5 beats/min). The intrinsic heart rate following dual autonomic blockade was also similar (HA␥ 2 -79h: 552 Ϯ 39 beats/ min; wild types: 517 Ϯ 50 beats/min), as was the response to isoproterenol (HA␥ 2 -79h: 748 Ϯ 25 beats/ min, wild types: 722 Ϯ 32 beats/min). Thus there was no difference between transgenic and wild-type mice in their response to autonomic blockade and sympathetic stimulation.
Cardiac electrophysiology. Table 3 summarizes the results of the endocardial electrophysiological study in the absence and presence of carbachol. Sinus node recovery times were slightly decreased in HA␥ 2 -79h mice compared with wild-type mice under baseline conditions, but the difference did not reach statistical significance. After muscarinic stimulation, sinus node recovery times were significantly shorter in the transgenic mice (see also Fig. 4, top) . In wild-type mice, the SNRT at at 200 pacing lengths (SNRT 200 ) increased by 80% compared with 37% in the transgenic mice, SNRT 150 by 74% compared with 31%, and SNRT 100 by 61% compared with 39%. There were no discernible differences in the modulation of atrioventricular conduction properties, atrioventricular nodal, or ventricular effective refractory periods between HA␥ 2 -79h and wild-type mice either under baseline conditions or after carbachol administration.
Arrhythmia inducibility. Under baseline experimental conditions, no atrial or ventricular arrhythmias were inducible with programmed atrial and ventricular stimulation techniques or burst-pacing protocols in either wild-type or transgenic mice. As illustrated in Fig. 4 , bottom, following pretreatment with carbachol, sustained atrial fibrillation with a mean duration of 79 Ϯ 147 s was reproducibly inducible with programmed extrastimuli or burst-pacing protocols in 19 of 26 wild-type mice (73%). In contrast, in only 3 of 13 transgenic mice (23%) was atrial fibrillation with a mean duration of 23 Ϯ 21 s inducible during the electrophysiological study (P Ͻ 0.05). In a subgroup of mice that were reproducibly inducible for arrhythmias, reinduction of atrial fibrillation was attempted after administration of atropine. None of these mice was any longer inducible. We did not observe supraventricular tachycardias, ventricular arrhythmias, or sudden cardiac death in any mouse under any condition tested.
DISCUSSION
Transgenic mouse model. Genetically modified mouse models are often utilized to examine the physiological role of signaling components under physiological conditions in the intact animal. We choose a transgenic approach to create a mouse model in which we could investigate the functional role of G␤␥-subunits for the regulation of heart rate control, cardiac conduction, and arrhythmogenesis. In the present study, we demonstrate that it is possible to significantly reduce the amount of endogenous G␤-subunits in cardiocyte membranes by trapping them in the cytosol with overexpressed nonprenylated HA␥ 2 [C68S]. As a result, less G␤ is available to form dimers with endogenous G␥-subunits, causing a reduction in the amount of functional G␤␥-dimers available for signal transduction. In contrast to targeted deletion, this approach causes a reduction in the amount of membrane-bound G␤ protein that is not limited to a particular isoform, because the G␥-subunits used as a trap, G␥ 2 , form dimers with all G␤-isoforms expressed in the heart equally well (35) . This was critical for the present study because it has been shown that G␤␥-dimers containing G␤ 1 -G␤ 4 bind to and activate K ACh current equally well (17, 34) .
A reduction in the amount of functional G␤␥-subunits can also be achieved by sequestration of G␤␥ with the COOH-terminal, G␤␥-binding domain of ␤-adrenoceptor kinase (␤ARK, see Ref. 13 ). However, because the interaction between G␤␥-subunits and ␤ARK is G␤␥-isoform specific (6, 24) , this approach is also likely to be limited to particular isoform combinations.
Interestingly, the amount of HA␥ 2 [C68S] expressed in the cytosol of transgenic mice increased between 3 wk and 6 mo of age. It is well established that the ␣-myosin heavy chain (␣-MHC) promoter is turned on in both atria and ventricles in adulthood (26) . To our knowledge, an increase in activity of the widely used ␣-MHC promoter that could explain the observed rise in transgene expression has not been described. It is therefore likely that mechanisms other than increased transcriptional activity (such as, for example, changes in mRNA stability and/or protein synthesis/stability) are involved. An insertional effect seems unlikely because the rise in transgenic protein expression was observed in two independent transgenic lines and in both hetero-and homozygous mice. Whereas the underlying mechanism for the rise in HA␥ 2 [C68S] expression remains to be elucidated, it is likely to largely contribute to the more pronounced reduction in membrane-bound G␤ observed in older transgenic mice.
Expression of G protein ␣-subunits. The reduction in the amount of membrane-bound G␤ protein in transgenic mice was accompanied by a reduction in the amount of G␣ s (and to a lesser degree G␣ i ). This observation may be indicative of coordination between G␣ and G␤␥ levels. It has been shown in brains of mice with a targeted deletion of G␣ o that the amount of G␤␥ protein is reduced (presumably due to enhanced degradation of "excess" G␤␥), so that it matches the amount of remaining G␣ subunits (22) . It is conceivable that the amount of G␣ s (and G␣ i ) in mice expressing HA␥ 2 [C68S] is reduced because less prenylated G␤␥ is available for heterotrimer formation. The affinity of nonprenylated G␤␥ for G␣-subunits is, in contrast to prenylated G␤␥, very low (10) .
Adenylyl cyclase activity. The response of AC to stimulation with isoproterenol (which activates G s indirectly through ␤-adrenoceptor stimulation), GTP␥S (which activates G proteins directly), and forskolin [which acts directly on the catalytic unit of AC but in synergy with G␣ s (2)] was blunted in the transgenic mice. This could at least partly be due to the decreased amount of G␣ s protein. However, we cannot exclude the possibility that the protein expression of the AC itself is also reduced in the transgenic mice, potentially contributing to the observed results. In contrast, the reduction in functional G␤␥ in the transgenic hearts is unlikely to play a role because the predominant cardiac AC isoforms (AC V and AC VI) are not modulated by G␤␥ (28) .
Modulation of electrophysiological characteristics. The main electrophysiological finding of our investigation was that G␤␥ is an important component in the Values are means Ϯ SD with time intervals (in ms, unless indicated otherwise); n ϭ no. of mice. SNRT, sinus node recovery time; AV, atrio-ventricular; AV Wenckebach, atrial pacing Wenckebach cycle length; AV 2:1, atrial pacing 2:1 AV block cycle length; ERP, effective refractory period and "200", "150" and "100" refer to the cycle lengths (in ms) of the pacing protocols. AVC (min CL), AV conduction minimum 1:1 cycle length. * P Ͻ 0.05 vs. wild-type controls; † P Ͻ 0.05 vs. baseline.
regulation of pacemaker activity and in the parasympathetic branch of signal transduction. Although evidence for a role of K ACh in vagal heart rate regulation has been shown in mice with targeted disruption of the GIRK 4 gene (33) , this report addresses the contribution of its upstream modulator G␤␥ to in vivo cardiac electrophysiological function and chronotropic heart rate regulation.
The mechanism implicated in abnormal impulse formation with enhancement of automaticity and altered autonomic control is that the deficiency in functional G␤␥-dimers leads to malfunction of the muscarinic receptor-mediated opening of K ACh . The resultant decrease in K ϩ permeability impairs hyperpolarization of sinoatrial nodal pacemaker cells with a decrease in the voltage difference between diastolic potential and voltage threshold, so that the slope of phase 4 depolarization is increased. The diminished bradycardic response of HA␥ 2 -79h mice to carbachol administration and baroreflex testing also suggests that impairment of K ACh current Fig. 4 . Sinus node function and atrial arrhythmias in WT and HA␥2-79h mice. Top: illustration of sinus node recovery time (SNRT) following right atrial pacing (S1) at cycle length of 150 ms in WT (left) and transgenic (right) mice treated with carbachol (0.05 mg/kg). Surface ECG lead I is displayed, followed by right ventricular and right atrial intracardiac electrograms (IECG, in mV). After 15 s of atrial pacing, the WT mouse SNRT is 752 ms compared with 422 ms in the transgenic mouse. Bottom: programmed right atrial (RA) burst stimulation following carbachol administration (0.05 mg/kg) provokes a rapid sustained atrial tachycardia in a WT mouse, whereas the same protocol did not induce atrial arrhythmia in a transgenic mouse. Surface ECG lead I is displayed on top followed by the right ventricular and right atrial intracardiac electrograms (in mV). Overall, 73% of WT mice, compared with only 23% of transgenic mice had inducible atrial tachyarrhythmias. may be responsible for the enhanced automaticity through an increased phase 4 depolarization slope.
Administration of high concentrations of atropine prevented a significant response to carbachol on heart rate and HRV, demonstrating that the effect of carbachol was mediated by muscarinic receptor stimulation.
Heart rate variability. HRV analysis was performed to interrogate abnormalities in autonomic regulation of cardiac rhythm that are not necessarily reflected in changes in mean heart rate. As the frequency components of the heart rate spectra are affected by both sympathetic and parasympathetic nervous systems inputs, HRV analysis allows quantification of their respective contributions. We found that the direct, membrane-delimited activation of K ACh is important for beat-to-beat modulation of heart rate by the autonomic nervous system, which functions on a second time scale, in contrast to the involvement of a second messenger system (cAMP) operating on a tens-of-seconds time scale (25) .
The observed differences in HRV between transgenic and wild-type mice at baseline suggest that G␤␥-subunits are integral for heart rate regulation, even when vagal tone is not elevated. The difference in HRV is exacerbated after vagal stimulation with carbachol. Carbachol leads to a dramatic increase in all time-and frequency-domain measures of HRV in wild-type but not HA␥ 2 -79h mice, indicating diminished vagal beatto-beat heart rate modulation. The most pronounced alterations are found in the low-frequency range, consistent with previous work on HRV in mice (8, 12, 19, 29) . It is further in agreement with the murine study on heart rate regulation in GIRK4 knockout mice (33) . The low-frequency component of the murine heart rate power spectrum receives both sympathetic and parasympathetic contributions with a large parasympathetic component to low-frequency power. In support of these findings, the arterial baroreflex-mediated cardioinhibition was also blunted in transgenic mice, suggesting that baroreflex-mediated enhancement in parasympathetic tone requires an appropriate amount of functional G␤␥-subunits.
Atrium and sinus node modulation. Transgenic mice exhibited shorter sinus node recovery times than wildtype mice after carbachol administration. This suggests that G␤␥-subunits play a role in sinus node automaticity and pacemaking function. Two potentially overlapping mechanisms could contribute to this effect. First, deficiency in functional G␤␥ is likely to cause malfunction of the repolarizing current K ACh , leading to impairment of K ϩ efflux, hyperpolarization, and inadequate decrease in phase 4 of the action potential. Thus one important vagal bradycardia mechanism could be impaired. In the sinoatrial node, most of the basal K ϩ conductance is due to K ACh , and in pacemaker cells any changes in its activity can alter excitability and heart rate (11) . Second, in addition to K ACh , ACh modulates the pacemaker current (I f ) in sinoatrial nodal cells (25, 36) . There are some important differences between I f and K ACh modulation. Heart rate control by inhibition of I f is achieved with moderate vagal stimulation or low doses of ACh, whereas stronger vagal activity or a higher concentration of ACh is required for greater bradycardia due to activation of K ACh (7) . Furthermore, I f regulation by muscarinic receptors is mediated by a second messenger (cAMP) and not by direct activation through G␤␥ (25) . Our data implicate alterations in K ACh regulation as the major underlying mechanism, because diminution in I f should have caused abnormalities in heart rate in transgenic mice under baseline conditions, (i.e., before muscarinic stimulation) and, in addition, prevention of vagal-provoked atrial fibrillation would have been unlikely. However, we cannot rule out secondary effects due to I f blockade and/or compensatory I f changes.
Vagal activity has been implicated in atrioventricular conduction properties. ACh and adenosine are known to cause a delay of atrioventricular node conduction. Our results of surface ECG recordings and electrophysiological study document the lack of significant differences between study groups in atrioventricular node function. Atrioventricular nodal block following carbachol was not observed in our study. Thus it appears, that G protein ␤␥-subunits are not critical for atrioventricular conduction in mice.
Arrhythmia vulnerability. Although one could have anticipated an increased propensity to atrial arrhythmias in the transgenic mice due to malfunction of a key regulatory conductance in pacemaker cells, there were no ambient arrhythmias detected during ambulatory ECG recordings without or with pharmacological manipulation. In contrast, disruption in the parasympathetic branch of signal transduction in HA␥ 2 -79h mice turned out to be protective for vagally mediated pacing-inducible atrial fibrillation in the presence of carbachol, because the incidence of this arrhythmia in both frequency and duration was markedly reduced in transgenic mice compared with their wild-type counterparts. Together with our recent finding that GIRK4 knockout mice are resistant to carbachol-mediated, pacing-induced atrial fibrillation (14) , the present study demonstrates the crucial role G␤␥ plays in vivo for K ACh -mediated, parasympathetic regulation of atrial arrhythmic vulnerability.
Under physiological conditions, muscarinic activation of K ACh channels in atrial myocardium can be antiarrhythmic or proarrhythmic, depending on the electrophysiological substrate. Decreasing the duration of the action potential and hyperpolarization of the resting membrane potential through K ACh activation suppress triggered activity and abnormal automaticity. Conversely, decreasing the duration of the action potential reduces refractoriness and wavelength, which potentially promotes reentrant arrhythmias (27) .
Conclusions and future implications. The present study demonstrates the feasibility of creating an in vivo mouse model with a deficiency in membranebound G␤␥-dimers by transgenic overexpression of nonprenylated G␥. We utilized this model to examine the physiological role of G␤␥ for heart rate regulation, sinus node activity, and arrhythmia vulnerability, particularly under vagal stimulation. Our data indicate that G␤␥ is a physiologically important component in the parasympathetic branch of cardiac signal transduction and critical in heart rate regulation. Reduction of functional G␤␥ produced abnormalities of beat-tobeat-control of cardiac activity and of spontaneous depolarization within the sinus node, which presumably reflects a malfunction of the atrial K ACh channel. We thereby provide direct in vivo electrophysiological evidence that the integrity of G␤␥-mediated signaling is vital to cardiac pacemaker activity in the sinoatrial node, effective heart rate regulation, cardiac automaticity, and arrhythmia susceptibility.
The novel transgenic model of cardiac G␤␥ deficiency may serve useful in future studies to examine the physiological role of G␤␥ in vivo for the modulation of other cardiac downstream effectors in both atria and ventricles.
